Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Amended 483
  6. /
  7. fusion iv pharmaceuticals, inc.
AMENDED 483
•fusion iv pharmaceuticals, inc. •December 2, 2019

FDA AMENDED_483 - fusion iv pharmaceuticals, inc. - December 02, 2019

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This AMENDED 483 record concerns fusion iv pharmaceuticals, inc. , with an inspection on December 2, 2019, issued by the Center for Devices and Radiological Health, covering devices.

Company
fusion iv pharmaceuticals, inc.
Inspection Date
December 2, 2019
Product Type
Devices
Office
Center for Devices and Radiological Health
People
  • Erika V. Butler (Compliance Officer / Investigator)
  • Navid Vahedi
Open in Dashboard

ID · cf825ad2-2b01-4ae3-8c4e-44a78d7120d0

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.